Home Tags Gilead Sciences

Tag: Gilead Sciences

Biotech Stock News (ARWR) (GILD) (HRTX) (VRTX)

Arrowhead Research (NASDAQ:ARWR) On September 24, 2015 shares of Arrowhead were up as much as 20% after announcing positive phase 2a trial results for its...

Gilead Sciences (GILD) Stock: Why Now Is The Time To Buy

Gilead Sciences, Inc (NASDAQ: GILD) If you follow CNA Finance, or any other website I write for, chances are that you know that Gilead Sciences...

Gilead Sciences (GILD) Stock: Short Interest Is Up

Gilead Sciences, Inc. (NASDAQ: GILD) Short interest in the stock market is an indicator that investors think that the value of a stock is likely...

Gilead Sciences (GILD) Recovers In A Big Way

Gilead Sciences, In. (NASDAQ: GILD) Gilead Sciences stock is having an incredible day in the market. As I predicted yesterday, the stock is making a...

Gilead Sciences (GILD) Stock Will Come Back Roaring

Gilead Sciences, Inc. (NASDAQ: GILD) The US market has had a rough time over recent days; there's absolutely no denying that. There's also no denying...

Gilead Sciences (GILD) Stock: Why Now Is The Time To Buy

Gilead Sciences, Inc. (NASDAQ: GILD) When you think of the top 3 companies in the biotechnology space, chances are that Gilead Sciences is one of...

Gilead Sciences (GILD) Continues To Climb, Can It Last?

Gilead Sciences, Inc. (NASDAQ: GILD) Gilead Sciences is what I believe to be one of the most under-appreciated stocks in the biotech space. However, I...

Gilead Sciences Climbs On Positive Earnings

Gilead Sciences, Inc. (NASDAQ: GILD) As expected, Gilead Sciences reported their earnings for the second quarter after the closing bell on Tuesday; and as I...

Top 5 Analysts to Watch Ahead of Gilead Sciences, Inc’s (GILD)...

By Sarah Roden Gilead Sciences, Inc. (NASDAQ:GILD) will release second quarter earnings on Tuesday, July 28 after the bell. The biopharmaceutical giant is most known...

Gilead Sciences (GILD) Earnings Likely To Be A Catalyst

Gilead Sciences, Inc. (NASDAQ: GILD) Gilead Sciences is seeing slight declines today. However, I don't think the declines are likely to last very long. As...

Bristol-Myers Squibb (BMY) Stock: Spiking On Rumor Of PFE Takeover

Bristol-Myers Squibb Co (NYSE: BMY) is is experiencing a relatively strong spike in the market at the moment, and for good reason. There are...

Reviews

TradeMiner Review: Is It Worth Your While?

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...